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An early increase in outbreaks of norovirus gastroen-
teritis characterised at the French National Reference 
Centre occurred this winter season. They were con-
current with an unusual pattern of circulating strains, 
with three predominant genotypes: the re-emergent 
variant GII.P4 2009-GII.4 2012 found in 28% of noro-
virus outbreaks and two new emergent recombinant 
strains GII.P16-GII.4 2012 and GII.P16-GII.2 never 
before observed in France, found in 24% and 14% of 
norovirus outbreaks, respectively. 
We report an early increase in norovirus (NoV) gastro-
enteritis outbreaks investigated during this 2016/17 
season at the French National Reference Centre for 
Gastroenteritis Viruses (NRCgev), compared with the 
previous season (Figure 1). Molecular characterisation 
and phylogenetic analysis of the strains responsible for 
these outbreaks showed that three predominant geno-
types were co-circulating, including two new emergent 
recombinant strains never before observed in France.
Laboratory investigation
From week 40 in 2016 to week 3 in 2017, 350 stool sam-
ples corresponding to 114 gastroenteritis outbreaks 
were investigated at the French NRCgev. NoV detec-
tion was performed by real-time RT-PCR as previously 
described [1]. A total of 222 stool samples, correspond-
ing to 87 outbreaks (76%), were positive for norovirus. 
In comparison, during the same period in 2015/16, 55 
of 76 outbreaks (72%) had been positive for norovirus 
(Figure 1). Interestingly, the increase in norovirus-pos-
itive outbreaks started earlier this winter season than 
in the previous season.
Two to three norovirus-positive specimens from 
each positive outbreak were genotyped as previ-
ously described [1], by sequencing a fragment of the 
RNA polymerase gene (open reading frame (ORF) 1) 
and a fragment of the capsid gene (ORF2). Genotype 
was determined using the Norovirus Genotyping Tool 
version 1.0 [2]. Furthermore, for a selection of samples 
for which ORF1 and ORF2 presented different geno-
types, direct sequencing of a 1,112 bp region spanning 
the 3’ end of ORF1 and the 5’ end of ORF2 was performed 
to confirm the recombination status. Amplification was 
performed using the primer set JV12/G2SKR. ORF1-
ORF2 amplification and sequencing confirmed a recom-
bination event for 27 samples. Nucleotide sequences 
of these samples were submitted to the GenBank data-
base under accession numbers KY817495 to KY817521. 
Figure 2 presents the diversity of NoV genotypes found 
in the current and the previous season, between week 
40 and week 3.
Three genotypes were predominant this season: the 
variant GII.P4 2009-GII.4 2012 found in 24 of 87 noro-
virus outbreaks (28%), the recombinant GII.P16-GII.4 
2012 in 21 outbreaks (24%), and the recombinant GII.
P16-GII.2 in 12 outbreaks (14%). Furthermore, 12 strains 
could only be partially characterised, 10 with a GII.4 
2012 capsid and two with a GII.2 capsid. In compari-
son, one single genotype GII.P17-GII.17 had predomi-
nated during the 2015/16 season (54% of outbreaks), a 
genotype that was rarely found at the beginning of the 
current season (n = 5; 6%).
Phylogenetic analysis showed that all the GII.P4 2009-
GII.4 2012 strains found in this study clustered with 
the strain GII.P4 2009-GII.4 2012 (GenBank KF199164) 
found in Denmark in March 2013 [3], in both the poly-
merase and capsid regions (Figures 3 and 4).
They also clustered in the sequenced capsid fragment 
with the reference strain GII.4 Sydney 2012 (JX459908) 
and with the GII.4 Melbourne 6623 (KX767083) found 
in Australia in June 2016 [4]. The polymerase region of 
the GII.P16-GII.4 2012 strains and GII.P16-GII.2 strains 
were all closely related to the GII.P16-GII.16 strain 
VannesL23/1999/FR (AY682551), but interestingly, they 
separated in two distinct clusters (Figure 3). Of note, 
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the polymerase sequence of the new recombinant GII.
P16-GII.2 GO831GerNRW (KY357449) found in Germany 
this winter season [5] appeared in the same cluster as 
the French GII.P16-GII.2 strains.
In the capsid region, the GII.P16-GII.2 strains clustered 
with the reference strain Melksham/1994/UK (X81879) 
and were closely related to the recombinant GII.P16-
GII.2 GO831GerNRW (KY357449) (Figure 4). Of note, 
two GII.2 capsid sequences for which no polymerase 
sequence could be determined also appeared in the 
same cluster. The capsid sequences of the GII.P16-
GII.4 2012 strains were closely related to the reference 
strains GII.4 Sydney 2012, but interestingly, they segre-
gated in a clearly distinct cluster from the GII.P4 2009-
GII.4 2012 (Figure 4). It has to be noted that of the 10 
GII.4 2012 strains for which polymerase gene amplifi-
cation and sequencing failed, eight clustered with the 
GII.P16-GII.4 2012 strains and two clustered with the 
GII.P4 2009-GII.4 2012 strains, suggesting that the for-
mer may bear a GII.16 polymerase genotype while the 
latter may bear a GII.4 polymerase genotype.
Discussion
We observed an unusual co-circulation of three norovi-
rus strains this winter season, including two emergent 
recombinant strains never before detected in France. 
The co-circulation of two strains has occasionally been 
observed, such as the 2006a with the 2006b variant, 
but this was geographically and temporally limited [6]. 
Usually and for more than 20 years, gastroenteritis epi-
demics reported all over the world have been linked to 
a single predominant strain, principally a succession 
every two to three years of GII.4 genotypic variants, 
including US95/96 1996, Farmington Hills 2002, Hunter 
2004, Den Haag 2006b, New Orleans 2009 and Sydney 
2012 [6-8]. Unexpectedly, in the winter of 2014/15, a 
GII.17 strain emerged in Asia and then replaced the pre-
viously predominant GII.4 Sydney 2012 [9]. In France, 
the GII.17 strain became predominant in the winter of 
2015/16 (data not shown). 
One of this season’s predominant strains, the variant 
GII.P4 2009-GII.4 2012, had already been detected 
in France during the seasons 2012/13, 2013/14 and 
2014/15, at a time when the variant Sydney 2012 
largely predominated, and to a lesser extent in 
2015/16, when the strain GII.17 predominated. This 
variant was described in Denmark and Italy during the 
season 2012/13 [3,10] and more recently in Australia 
in August 2015 and as an altered version in June 2016 
[4]. Interestingly, the Australian authors suggested that 
this current recombinant strain could have the poten-
tial to become a pandemic variant [4]. However, the 
partial sequences of the capsid gene obtained in our 
laboratory do not provide enough information to differ-
entiate between the 2012/13 variant and the derivative, 
and further molecular investigations are needed.
The two recombinant strains GII.P16-GII.4 2012 and GII.
P16-GII.2 had never been observed in France before this 
winter season and have to our knowledge never been 
reported as major strains responsible for outbreaks 
in any country before this season. Although they were 
circulating concurrently this season in Germany, the 
reported pattern of circulating strains was different 
from what was observed in France [5]. Indeed, the GII.
P16-GII.2 was the predominant strain responsible for 
42% of outbreaks in Germany, far ahead of the variant 
GII.P4 2009-GII.4 2012 (10%) and the recombinant GII.
P16-GII.4 2012 (10%), while in France it was third after 
GII.P4 2009-GII.4 2012 and GII.P16-GII.4. The reasons 
Figure 1
Cumulative number of norovirus outbreaks investigated at 
the French National Reference Centre for Gastroenteritis 
Viruses, France, week 40 to week 3, 2015/16 (n = 55) and 
2016/17 (n = 87)
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Figure 2
Diversity of norovirus genotypes found at the French 
National Reference Centre for Gastroenteritis Viruses, 
France, week 40 to week 3, 2015/16 (n = 61) and 2016/17 
(n = 90)
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Figure 3
Phylogenetic tree based on the partial nucleotide sequences (287 bp) of the norovirus polymerase gene
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Phylogeny was reconstructed using the maximum-likelihood method implemented in MEGA6 [11] with the Kimura 2-parameter substitution model (i.e. best 
nucleotide substitution model for the dataset). The number of substitutions per site is indicated by the scale bar. Bootstrap values were calculated for 500 
replicates and are indicated at each node when ≥ 50%. French norovirus strains from this study are labelled as follows: full circles for GII.P16-GII.4, full triangles 
for GII.P16-GII.2 and full squares for GII.P4-GII.4.
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for these differences are unclear. One could be the set-
ting of the outbreaks, since the majority of the investi-
gated outbreaks in France occurred in nursing homes 
(73%), while in Germany, they occurred mainly in child-
care facilities (56% vs 17% in nursing homes). However, 
a complete assessment will be necessary at the end 
of the season to draw any conclusions about the pat-
tern of predominant circulating strains in France, since 
the data reported here concern the outbreaks inves-
tigated between week 40 in 2016 and week 3 in 2017 
and the gastroenteritis outbreak season is not yet over. 
Already, according to the phylogenetic analysis of the 
capsid sequences, it seems that GII.P16-GII.4 strains 
could be more prevalent than the GII.P4 2009-GII.4 
2012 variants. Further molecular and epidemiological 
investigations are needed to confirm this tendency.
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Phylogeny was reconstructed using the maximum-likelihood method implemented in MEGA6 [11] with 
the Kimura 2-parameter substitution model (i.e. best nucleotide substitution model for the dataset). 
The number of substitutions per site is indicated by the scale bar. Bootstrap values were calculated 
for 500 replicates and are indicated at each node when ≥ 50%. French norovirus strains from this study 
are labelled as follows: full and empty circles, respectively, for GII.P16-GII.4 and GII.4 strains probably 
bearing a GII.P16 genotype; full and empty triangles, respectively, for GII.P16-GII.2 and GII.2 strains 
probably bearing a GII.P16 genotype; full and empty squares, respectively, for GII.P4-GII.4 and GII.4 
strains probably bearing a GII.P4 genotype.
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